Current Medical Research and Opinion

Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study
pp. 809-821(13)
Authors: Lundborg, Mikael; Wille, Sören; Bjermer, Leif; Tilling, Björn; Lundgren, Michael; Telg, Gunilla; Ekström, Tommy; Selroos, Olof

Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis
pp. 823-835(13)
Authors: Ose, Leiv; Shah, Arvind; Davies, Michael J.; Rotonda, Jennifer; Maccubbin, Darbie; Tribble, Diane; Veltri, Enrico; Mitchel, Yale

Dosing patterns, hematologic outcomes, and costs of erythropoietic agents in predialysis chronic kidney disease patients with anemia
pp. 837-842(6)
Authors: Papatheofanis, Frank J.; McKenzie, R. Scott; Mody, Samir H.; Suruki, Robert Y.; Piech, Catherine Tak

Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience
pp. 843-850(8)
Authors: Tennenberg, Alan M.; Davis, Neelam B.; Wu, Shu-Chen; Kahn, James

Improving the global management of the neurogenic bladder patient: part II. Future treatment strategies
pp. 851-860(10)
Authors: Denys, Pierre; Corcos, Jacques; Everaert, Karel; Chartier-Kastler, Emmanuel; Fowler, Clare; Kalsi, Vinay; Nitti, Victor; Schulte-Baukloh, Heinrich; Schurch, Brigitte

Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes
pp. 861-872(12)
Authors: Palmer, Andrew J.; Dinneen, Sean; Gavin, James R.; Gray, Alastair; Herman, William H.; Karter, Andrew J.

Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
pp. 873-883(11)
Authors: Athyros, Vasilios G.; Mikhailidis, Dimitri P.; Didangelos, Triandafillos P.; Giouleme, Olga I.; Liberopoulos, Evangelos N.; Karagiannis, Asterios; Kakafika, Anna I.; Tziomalos, Konstantinos; Burroughs, Andrew K.; Elisaf, Moses S.

Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis
pp. 885-895(11)
Authors: Ponseti, José M.; Azem, Jamal; Fort, José M.; López-Cano, Manuel; Vilallonga, Ramón; Gamez, Josep; Armengol, Manuel

The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries
pp. 897-905(9)
Authors: Holmstrom, Stefan; Buchholz, Patricia; Walt, John; Wickstrøm, Jannie; Aagren, Mark

Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients
pp. 907-918(12)
Authors: Howles, C.M.; Saunders, H.; Alam, V.; Engrand, P.; The FSH Treatment Guidelines Clinical Panel,

Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis
pp. 919-928(10)
Authors: Iwamoto, Jun; Takeda, Tsuyoshi; Sato, Yoshihiro

A comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: a 6-month study
pp. 929-937(9)
Authors: Kung, A.W.C.; Pasion, E.G.; Sofiyan, M.; Lau, E.M.C.; Tay, B.K.; Lam, K.S.; Wilawan, K.; Ongphiphadhanakul, B.; Thiebaud, D.

Correlation of improved erectile function and rate of successful intercourse with improved emotional well-being assessed with the Self-Esteem And Relationship questionnaire in men treated with sildenafil for erectile dysfunction and stratified by age
pp. 939-948(10)
Authors: Steidle, Christopher P.; Stecher, Vera J.; Pace, Cindy; Tseng, Li-Jung; The SEAR Study Group,

An evaluation of patient preferences for osteoporosis medication attributes: results from the PREFER-US study
pp. 949-960(12)
Authors: Weiss, Thomas W.; Gold, Deborah T.; Silverman, Stuart L.; McHorney, Colleen A.

Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes
pp. 961-966(6)
Authors: Shi, Lizheng; Juarez, Rodrigo; Hackworth, Jodi; Edgell, Eric T.; Haro, Josep Maria; Vieta, Eduard; Tohen, Mauricio F.

Comments and reply on: Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting
pp. 967-969(3)
Authors: Currie, Craig J.; McEwan, Phil; Poole, Chris; Valentine, William J.; Palmer, Andrew J.; Lammert, Morten; Nicklasson, Lars; Foos, Volker; Roze, Stéphane

Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost
pp. 971-976(6)
Authors: Covert, David; Robin, Alan L.

Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac – an Indian experience
pp. 977-988(12)
Authors: Pareek, A.; Chandanwale, A.S.; Oak, J.; Jain, U.K.; Kapoor, S.

Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001–2002
pp. 989-1000(12)
Authors: Robinson, Don; Hackett, Monica; Wong, John; Kimball, Alexa B.; Cohen, Russell; Bala, Mohan; The IMID Study Group,

International INtegrated Database for the Evaluation of severe sePsis and drotrecogin alfa (activated) THerapy: component trials and statistical methods for INDEPTH
pp. 1001-1012(12)
Authors: Sashegyi, Andreas; Trzaskoma, Benjamin L.; Nelson, David R.; Williams, Mark D.; Macias, William

Type 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications
pp. 1013-1020(8)
Authors: Eppens, Maike C.; Craig, Maria E.; Jones, Timothy W.; Silink, Martin; Ong, Stephanie; Ping, Yeo Jing; The International Diabetes Federation Western Pacific Region Steering Committee,